NCT02769962 2025-07-28
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
National Institutes of Health Clinical Center (CC)
Xuzhou Central Hospital
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Candiolo Cancer Institute - IRCCS
Cancer Prevention and Research Institute, Italy
Taichung Veterans General Hospital